SMS Lifesciences India Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

SMS Lifesciences India Share Price

1,260.20-34.75 (-2.69%)

Closed
As On: 28 Jan, 2025, 03:40 PM IST
As On: 28 Jan, 2025, 03:50 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	1,354.95
High	1,354.95
Low	1,254.30
Prev Close	1,294.95
Volume	972
VWAP(₹)	1,304.63

SMS Lifesciences Ind share price insights

Employee & Interest Expense
Company has spent 3.32% of its operating revenues towards interest expenses and 16.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 68.26% as compared to Nifty Smallcap 100 which gave a return of 48.33%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 68.26% return as compared to Nifty Pharma which gave investors 64.0% return over 3 year time period. (as of last trading session)
SMS Lifesciences Ind Share Price Update
SMS Lifesciences India Ltd. share price moved down by -2.69% from its previous close of Rs 1,294.95. SMS Lifesciences India Ltd. stock last traded price is 1,260.20
Share Price Value
Today/Current/Last 1,260.201,269.00
Previous Day 1,294.951,282.15

Found Insights useful?

SMS Lifesciences Ind Share Price Returns

1 Day	-2.69%
1 Month	4.89%
3 Months	-10.44%
1 Year	117.16%
3 Years	68.26%
5 Years	363.91%

Key Metrics

PE Ratio(x)	17.41
EPS - TTM(₹)	72.37
MCap(₹ Cr.)	380.99
MCap Rank	89
PB Ratio(x)	2.02
Div Yield(%)	0.12
Face Value(₹)	10.00
52W High(₹)	1,749.65
52W Low(₹)	538.20
MCap/Sales	0.67
Beta(1 Month)	1.45
BV/Share(₹)	640.48

SMS Lifesciences Ind Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

SMS Lifesciences Ind News & Analysis

Stock market update: Nifty IT index advances 0.17% in a weak market
News
Newspaper Publication (Postal Ballot)
Announcements
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Announcements
USFDA Update (Material Subsidiary)
Announcements

View all SMS Lifesciences Ind Share News & Announcements

SMS Lifesciences Ind Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

SMS Lifesciences Ind Financials

	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Income	80.50	92.99	92.35	72.64	69.60
Total Income Growth (%)	-13.43	0.69	27.15	4.37	-7.53
Total Expenses	73.66	79.94	82.41	66.49	65.13
Total Expenses Growth (%)	-7.86	-3.00	23.96	2.08	-14.09
EBIT	6.84	13.05	9.94	6.15	4.47
EBIT Growth (%)	-47.57	31.25	61.64	37.69	-
Profit after Tax (PAT)	4.67	7.00	5.90	4.30	0.67
PAT Growth (%)	-33.23	18.53	37.18	545.94	-
EBIT Margin (%)	8.50	14.03	10.76	8.47	6.42
Net Profit Margin (%)	5.80	7.53	6.39	5.93	0.96
Basic EPS (₹)	15.46	23.15	19.53	14.24	-2.20

	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Income	79.75	87.00	88.65	71.87	68.18
Total Income Growth (%)	-8.33	-1.86	23.35	5.42	-9.27
Total Expenses	69.27	75.30	78.18	64.75	60.92
Total Expenses Growth (%)	-8.02	-3.68	20.74	6.29	-15.34
EBIT	10.49	11.70	10.47	7.12	7.25
EBIT Growth (%)	-10.35	11.73	47.11	-1.88	128.20
Profit after Tax (PAT)	6.01	6.46	5.93	3.31	3.12
PAT Growth (%)	-6.99	8.88	79.01	6.33	344.98
EBIT Margin (%)	13.15	13.44	11.81	9.90	10.64
Net Profit Margin (%)	7.53	7.43	6.69	4.61	4.57
Basic EPS (₹)	19.87	21.37	19.63	10.96	10.31

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	309.79	318.63	351.81	267.37	263.06
Total Revenue Growth (%)	-2.78	-9.43	31.58	1.64	-30.84
Total Expenses	299.94	304.39	331.77	247.81	248.39
Total Expenses Growth (%)	-1.46	-8.25	33.88	-0.24	-30.03
Profit after Tax (PAT)	9.09	11.46	25.32	13.56	10.18
PAT Growth (%)	-20.68	-54.73	86.79	33.13	-42.94
Operating Profit Margin (%)	6.53	6.66	7.49	9.07	7.59
Net Profit Margin (%)	2.97	3.63	7.24	5.10	3.90
Basic EPS (₹)	30.08	37.92	83.61	44.84	33.68

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	303.84	318.12	347.16	261.59	258.81
Total Revenue Growth (%)	-4.49	-8.36	32.71	1.07	-25.35
Total Expenses	284.73	302.10	326.88	242.23	245.47
Total Expenses Growth (%)	-5.75	-7.58	34.94	-1.32	-23.98
Profit after Tax (PAT)	13.07	13.22	25.38	13.17	9.15
PAT Growth (%)	-1.15	-47.92	92.75	43.96	-45.01
Operating Profit Margin (%)	9.33	6.69	7.20	9.16	7.17
Net Profit Margin (%)	4.35	4.19	7.34	5.05	3.56
Basic EPS (₹)	43.22	43.72	83.95	43.56	30.26

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 3.32% of its operating revenues towards interest expenses and 16.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	390.52	394.89	356.75	302.30	252.83
Total Assets Growth (%)	-1.11	10.69	18.01	19.57	-6.29
Total Liabilities	196.88	206.67	191.82	173.08	137.10
Total Liabilities Growth (%)	-4.74	7.74	10.83	26.25	-16.13
Total Equity	193.64	188.22	164.93	129.22	115.73
Total Equity Growth (%)	2.88	14.12	27.64	11.65	8.84
Current Ratio (x)	1.07	1.19	1.15	1.11	1.23
Total Debt to Equity (x)	0.55	0.59	0.51	0.46	0.50
Contingent Liabilities	42.17	49.00	67.66	59.91	71.12

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	347.38	337.39	312.00	271.74	228.95
Total Assets Growth (%)	2.96	8.14	14.82	18.69	-8.68
Total Liabilities	171.15	173.36	160.79	145.41	115.69
Total Liabilities Growth (%)	-1.27	7.82	10.58	25.69	-20.61
Total Equity	176.23	164.03	151.21	126.34	113.26
Total Equity Growth (%)	7.44	8.48	19.68	11.55	7.89
Current Ratio (x)	1.42	1.52	1.36	1.30	1.27
Total Debt to Equity (x)	0.50	0.52	0.40	0.33	0.39
Contingent Liabilities	50.84	61.38	80.77	69.79	83.16

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	24.31	14.70	-11.24	35.17	14.55
Net Cash used in Investing Activities	-18.45	-31.29	-7.14	-26.23	-27.02
Net Cash flow from Financing Activities	-6.56	16.89	10.83	-2.55	12.45
Net Cash Flow	-0.71	0.29	-7.55	6.39	-0.03
Closing Cash & Cash Equivalent	0.57	1.28	0.99	8.54	2.15
Closing Cash & Cash Equivalent Growth (%)	-55.43	29.58	-88.45	297.44	-1.24
Total Debt/ CFO (x)	4.02	6.71	-6.87	1.69	3.96

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	14.75	4.58	-14.66	21.62	13.95
Net Cash used in Investing Activities	-13.75	-27.96	-7.49	-5.94	-13.28
Net Cash flow from Financing Activities	-0.82	22.59	14.63	-7.87	-2.05
Net Cash Flow	0.18	-0.80	-7.52	7.81	-1.38
Closing Cash & Cash Equivalent	0.33	0.15	0.95	8.46	0.65
Closing Cash & Cash Equivalent Growth (%)	121.20	-84.00	-88.82	1,193.32	-67.77
Total Debt/ CFO (x)	6.01	18.61	-4.08	1.93	3.20

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 18.45 cr for investing activities which is an YoY decrease of 41.04%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	5.14	6.79	16.63	10.49	8.79
Return on Capital Employed (%)	8.13	8.04	11.84	12.77	11.94
Return on Assets (%)	2.32	2.90	7.09	4.48	4.02
Interest Coverage Ratio (x)	3.44	4.68	5.87	5.32	3.86
Asset Turnover Ratio (x)	0.78	0.84	1.13	87.85	103.14
Price to Earnings (x)	22.57	13.72	8.30	11.04	5.20
Price to Book (x)	1.16	0.93	1.38	1.16	0.46
EV/EBITDA (x)	9.11	8.52	8.16	6.19	3.72
EBITDA Margin (%)	11.42	10.08	10.35	12.03	10.60

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	7.41	8.05	16.78	10.42	8.07
Return on Capital Employed (%)	12.46	9.30	12.90	14.26	12.35
Return on Assets (%)	3.76	3.91	8.13	4.84	3.99
Interest Coverage Ratio (x)	4.30	5.75	7.11	5.30	3.62
Asset Turnover Ratio (x)	0.88	0.97	1.18	95.77	112.22
Price to Earnings (x)	15.72	11.90	8.29	11.36	5.79
Price to Book (x)	1.16	0.96	1.39	1.18	0.47
EV/EBITDA (x)	7.65	8.24	8.14	5.88	3.71
EBITDA Margin (%)	12.75	9.29	9.51	11.93	9.99

Found Financials useful?

SMS Lifesciences Ind Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

SMS Lifesciences Ind Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
SMS Lifesciences Ind	17.41	1.97	5.14	8.13	2.32	4.98	6.53	2.06	30.08	1.07	0.55	4.02
Medico Remedies	78.75	11.55	15.83	22.77	8.61	5.95	8.38	5.72	1.00	1.72	0.13	0.00
Medicamen Bio	80.36	2.70	5.28	8.32	3.71	16.79	9.74	5.29	7.50	1.89	0.15	-4.57
Lyka Labs	145.43	7.26	-3.65	3.66	-1.58	8.57	3.92	-2.35	-0.79	1.35	0.81	31.29
Kilitch Drug	30.50	2.86	8.28	14.37	6.08	30.33	16.37	8.79	9.17	2.27	0.18	-216.31
Add More

Annual Ratios (%)

Choose from Peers

Zim Laboratories
Brooks Labs
Venus Remedies
Par Drugs & Chemical
Alpa Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 68.26% as compared to Nifty Smallcap 100 which gave a return of 48.33%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 68.26% return as compared to Nifty Pharma which gave investors 64.0% return over 3 year time period. (as of last trading session)

SMS Lifesciences Ind Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 21,58,789 71.41 % 0.00
Pledge 0 0.00 % 0.00
FII 732 0.02 % 0.01
Others 8,63,766 28.59 % 0.01
QoQ Change
Category 31 Dec 2024 30 Sep 2024 30 Jun 2024 31 Mar 2024
Promoters 71.41 71.41 71.41 71.19
Pledge 0.00 0.00 0.00 0.00
FII 0.00 0.02 0.01 0.00
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 28.59 28.57 28.58 28.81

Mutual Funds Ownership

No Data Available

SMS Lifesciences Ind Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results
Nov 08, 2024
General Meeting
Rs.1.5000 per share(15%)Dividend & A.G.M.
Aug 27, 2024
Board Meeting
Quarterly Results & A.G.M.
Aug 06, 2024

Announced on	Meeting on
Nov 08, 2024	Nov 13, 2024
Quarterly Results
Aug 06, 2024	Aug 09, 2024
Quarterly Results & A.G.M.
May 21, 2024	May 27, 2024
Audited Results & Dividend
Feb 05, 2024	Feb 10, 2024
Quarterly Results & Others
Nov 06, 2023	Nov 11, 2023
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 27, 2024 Sep 23, 2024 15%
May 29, 2023 Sep 22, 2023 15%
May 30, 2022 Sep 22, 2022 15%
Jun 18, 2021 Sep 20, 2021 15%
May 30, 2019 Sep 19, 2019 15%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Aug 27, 2024	Sep 30, 2024
Rs.1.5000 per share(15%)Dividend & A.G.M.
Aug 21, 2023	Sep 29, 2023
A.G.M. & Rs.1.5000 per share(15%)Dividend
Aug 21, 2020	Sep 30, 2020
-
Aug 13, 2019	Sep 30, 2019
Book closure from Sep 23, 2019 to Sep 30, 2019
Aug 28, 2018	Sep 20, 2018
Book closure from Sep 15, 2018 to Sep 20, 2018

About SMS Lifesciences Ind

SMS Lifesciences India Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 380.99 Crore) operating in Pharmaceuticals sector.

SMS Lifesciences India Ltd. key Products/Revenue Segments include Pharmaceuticals, Conversion Charges, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.

For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 80.50 Crore, down 13.43 % from last quarter Total Income of Rs 92.99 Crore and up 15.67 % from last year same quarter Total Income of Rs 69.60 Crore. Company has reported net profit after tax of Rs 3.30 Crore in latest quarter.

The company’s top management includes Mr.TVVSN Murthy, Mrs.Sudeepthi Gopineedi, Mr.T V Praveen, Dr.Mannam Malakondaiah, Mr.P Sarath Kumar, Dr.Srinivas Samavedam, Mr.N Rajendra Prasad, Mr.Trupti Ranjan Mohanty. Company has Rambabu & Co. as its auditors. As on 31-12-2024, the company has a total of .30 Crore shares outstanding.

SMS Lifesciences Ind Share Price Today is Rs. 1260.20. On previous day, the SMS Lifesciences Ind Share Price (NSE) closed at Rs. 1234.0, featuring among the most traded securities on the National Stock Exchange.

Stock Forecast:
After showing 80.5 Cr. of sales and 13.43% of quarterly net loss, there have been multiple ups and downs in the SMS Lifesciences Ind stock prices in the past few weeks. For example, SMS Lifesciences Ind stock price on 20th of January 2025 was around Rs. 1270.0. SMS Lifesciences Ind share price now stands at an average of Rs. 1260.20. Judging by last week's performance, stock is in down trend.

SMS Lifesciences Ind has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for SMS Lifesciences Ind share.

Historical Prices and Performance:
SMS Lifesciences Ind, incorporated in 2006 is a Small Cap company (with a market cap of Rs. 391.5) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by SMS Lifesciences Ind stock was 5.14%, 6.79%, 16.63%, 10.49% and 8.79% respectively.
The SMS Lifesciences Ind share gave a 3 year return of 83.84% as compared to Nifty 50 which gave a return of 33.42%.
SMS Lifesciences Ind announced 15.0% final dividend on September 23, 2024.

Key Metrics:
PE Ratio of SMS Lifesciences Ind is 17.05
Prices/Sales Ratio of SMS Lifesciences Ind is 0.67
Price/Book Ratio of SMS Lifesciences Ind is 1.93

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For SMS Lifesciences Ind, major competitors and peers include Medico Remedies, Medicamen Bio, Lyka Labs and Kilitch Drug. As of Sep 2024, the dividend yield of SMS Lifesciences Ind stands at 0.12% while Medico Remedies, Medicamen Bio, Lyka Labs and Kilitch Drug stand at 0.0%, 0.22%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 17.05 and 1.93 respectively.

Leadership of SMS Lifesciences Ind :
N Rajendra Prasad is Chief Financial Officer
Trupti Ranjan Mohanty is Co. Secretary & Compl. Officer
TVVSN Murthy is Managing Director
T V Praveen is Executive Director
Sudeepthi Gopineedi is Whole Time Director
P Sarath Kumar is Independent Director
Srinivas Samavedam is Independent Director
Mannam Malakondaiah is Independent Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Plot No.19-III,Road No.71,Opp. Bharatiya Vidya Bhavan Public School,Hyderabad, Telangana - 500096

Contact

[email protected]

http://www.smslife.in

Executive Leadership

TM

TVVSN Murthy

Managing Director

SG

Sudeepthi Gopineedi

Whole Time Director

TV

T V Praveen

Executive Director

MM

Mannam Malakondaiah

Independent Director

Show More

Auditors

Rambabu & Co.

FAQs about SMS Lifesciences Ind share

1. What is SMS Lifesciences Ind share price and what are the returns for SMS Lifesciences Ind share?
As of today SMS Lifesciences Ind share price is down by 2.69% basis the previous closing price of Rs 1,234. SMS Lifesciences Ind share price was Rs 1,260.20. Return Performance of SMS Lifesciences Ind Shares:
- 1 Week: SMS Lifesciences Ind share price moved down by 1.08%
- 1 Month: SMS Lifesciences Ind share price moved up by 4.89%
2. What is 52 week high/low of SMS Lifesciences Ind share price?
SMS Lifesciences Ind share price saw a 52 week high of Rs 1,749.65 and 52 week low of Rs 538.20.
3. Who are peers to compare SMS Lifesciences Ind share price?
Within Pharmaceuticals sector SMS Lifesciences Ind, Venus Remedies Ltd., Lyka Labs Ltd., Zim Laboratories Ltd., Brooks Laboratories Ltd., Medicamen Biotech Ltd., Medico Remedies Ltd., Kilitch Drugs(I) Ltd., Vaishali Pharma Ltd., Par Drugs & Chemicals Ltd. and Alpa Laboratories Ltd. are usually compared together by investors for analysis.
4. What are the SMS Lifesciences Ind quarterly results?
Total Revenue and Earning for SMS Lifesciences Ind for the year ending 2024-03-31 was Rs 309.79 Cr and Rs 9.09 Cr on Consolidated basis. Last Quarter 2024-09-30, SMS Lifesciences Ind reported an income of Rs 80.50 Cr and profit of Rs 4.67 Cr.
5. What's the market capitalization of SMS Lifesciences Ind?
Market Capitalization of SMS Lifesciences Ind stock is Rs 380.99 Cr.
6. Who's the owner of SMS Lifesciences Ind?
7. What is the CAGR of SMS Lifesciences Ind?
The CAGR of SMS Lifesciences Ind is 3.6.
8. What are the returns for SMS Lifesciences Ind share?
Return Performance of SMS Lifesciences Ind Shares:
- 1 Week: SMS Lifesciences Ind share price moved down by 1.08%
- 1 Month: SMS Lifesciences Ind share price moved up by 4.89%
9. What are the key metrics to analyse SMS Lifesciences Ind Share Price?
SMS Lifesciences Ind share can be quickly analyzed on following metrics:
- Stock's PE is 17.41
- Price to Book Ratio of 2.02
10. What dividend is SMS Lifesciences Ind giving?
SMS Lifesciences India Ltd. announced an equity dividend of 15% on a face value of 10.0 amounting to Rs 1.5 per share on 27 May 2024. The ex dividend date was 23 Sep 2024.
11. What is the PE & PB ratio of SMS Lifesciences Ind?
The PE ratio of SMS Lifesciences Ind stands at 17.89, while the PB ratio is 2.02.

Top Gainers

As on 03:57 PM | 28 Jan 2025

95.71

6.73 (7.57%)

Aadhar Housing Fin

391.10

26.96 (7.41%)

1,280.30

86.30 (7.23%)

Chola Inv Finance

1,241.70

66.36 (5.65%)

Balkrishna Ind.

2,706.15

141.50 (5.52%)

Top Losers

As on 03:59 PM | 28 Jan 2025

534.50

-133.61 (-20.00%)

Apar Industries

7,173.70

-1790.10 (-19.98%)

9,621.75

-1310.00 (-11.99%)

Kaynes Technology

4,661.35

-606.70 (-11.52%)

Netweb Technologies

1,461.50

-162.35 (-10.00%)

Equity Quick Links

Top Gainers
Top Losers
Stock Recommendations
Stock Screener
Candlestick Screener
Upcoming Dividends
Volume Shockers
Hourly losers
Hourly gainers

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.